Aytu Debt Equity Ratio from 2010 to 2024

AYTU Stock  USD 1.38  0.04  2.99%   
Aytu BioScience Debt Equity Ratio yearly trend continues to be comparatively stable with very little volatility. Debt Equity Ratio will likely drop to 0.01 in 2024. From the period from 2010 to 2024, Aytu BioScience Debt Equity Ratio quarterly data regression had r-value of  0.63 and coefficient of variation of  167.31. View All Fundamentals
 
Debt Equity Ratio  
First Reported
2010-12-31
Previous Quarter
0.54585799
Current Value
0.00577066
Quarterly Volatility
0.18102783
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 4.6 M or Selling General Administrative of 12.1 M, as well as many indicators such as Price To Sales Ratio of 304, Dividend Yield of 0.0 or PTB Ratio of 3.34. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.
  
Check out the analysis of Aytu BioScience Correlation against competitors.
For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Latest Aytu BioScience's Debt Equity Ratio Growth Pattern

Below is the plot of the Debt Equity Ratio of Aytu BioScience over the last few years. It is Aytu BioScience's Debt Equity Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aytu BioScience's overall financial position and show how it may be relating to other accounts over time.
Debt Equity Ratio10 Years Trend
Slightly volatile
   Debt Equity Ratio   
       Timeline  

Aytu Debt Equity Ratio Regression Statistics

Arithmetic Mean0.11
Geometric Mean0.03
Coefficient Of Variation167.31
Mean Deviation0.14
Median0.01
Standard Deviation0.18
Sample Variance0.03
Range0.5401
R-Value0.63
Mean Square Error0.02
R-Squared0.39
Significance0.01
Slope0.03
Total Sum of Squares0.46

Aytu Debt Equity Ratio History

2024 0.005771
2023 0.55
2022 0.38
2021 0.39
2020 0.2

About Aytu BioScience Financial Statements

Aytu BioScience shareholders use historical fundamental indicators, such as Debt Equity Ratio, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Debt Equity Ratio 0.55  0.01 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.